Le Lézard
Classified in: Health
Subject: TRI

First performance standards published to measure the effectiveness of lifestyle medicine treatments


The measures are significant because adopting standards to document remission and long term-progress can facilitate the broader integration of lifestyle medicine into healthcare.

ST. LOUIS, March 28, 2024 /PRNewswire-PRWeb/ -- An expert panel has published the first performance measures to identify remission and evaluate the effectiveness of lifestyle medicine treatments, which will allow more objective comparisons between lifestyle behavior interventions and other non-lifestyle treatments.

"These new performance measures defined by the expert panel will help clinicians adopt evidence-based lifestyle medicine by equipping them with the standards they need to measure the success of those treatments."

The performance measures are significant because, as interest in the field of lifestyle medicine has grown, it became clear that the lack of standards to document remission or long-term progress following lifestyle medicine treatment was a barrier to the widespread integration of the practice into healthcare, said American College of Lifestyle Medicine Founding President John Kelly, MD, MPH, DipABLM, FACLM, lead author of the paper published in the American Journal of Lifestyle Medicine.

Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity. Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions. Applying the six pillars of lifestyle medicine?a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, positive social connections, and avoidance of risky substances?also provides effective prevention for these conditions.

"Many clinical practice guidelines call it important to address lifestyle behaviors in the treatment of chronic disease but, without measurable performance standards, it was not possible to effectively evaluate progress or long-term outcomes for patients following lifestyle medicine interventions," Dr. Kelly said. "These new performance measures defined by the expert panel will help clinicians adopt evidence-based lifestyle medicine by equipping them with the standards they need to measure the success of those treatments."

The expert panel focused on 10 diseases, conditions or risk factors and proposes using outcomes collected after three months of treatment with lifestyle medicine. The conditions included cardiac function, cardiac risk factors, cardiac medications and procedures, patient-centered cardiac health, hypertension, type 2 diabetes and prediabetes, metabolic syndrome, inflammatory conditions, inflammatory condition patient-centered measures, and chronic kidney disease. Patient-centered measures are metrics relevant to patient experience, such as quality of life or pain assessments.

For each disease, specific measurements were chosen to demonstrate if lifestyle medicine should be considered effective. For example, to measure the effectiveness of lifestyle medicine treatment for hypertension, the panel identified systolic and diastolic blood pressure three months after starting lifestyle interventions to address a poor diet and lack of exercise. The panel also considered important the use of medication or procedures with known effects on hypertension. Ultimately, 32 performance measures reached consensus.

The process for developing the performance measures made clear the need for a set of standards showing the effectiveness of lifestyle medicine, said Micaela Karlsen, PhD, MSPH, senior director of research for the American College of Lifestyle Medicine and last author of the paper.

"You would not expect surgery, a procedure or medication to be prescribed if no evidence existed that it worked," Dr. Karlsen said. "Our hope is these standards will be widely adopted by health practitioners."

As the field of lifestyle medicine continues to grow, the measurements will play an important role. Future work should use these measurements in data collection in the electronic medical record (EMR) system to standardize evaluation of lifestyle medicine treatment effectiveness and performance, the panel recommended.

ABOUT ACLM
The American College of Lifestyle Medicine is the nation's medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole-person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management.

Media Contact

alex branch, American College of Lifestyle Medicine, 19719835383, [email protected]

SOURCE American College of Lifestyle Medicine


These press releases may also interest you

at 11:55
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K...

at 11:30
The National Alliance on Mental Illness Greater L.A. County (NAMI GLAC) will celebrate its 20th annual NAMIWalks Greater LA County Mental Health Festival during Mental Health Awareness Month on Saturday, May 4, 2024. This free community wide event at...

at 10:30
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: